<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Vet Res</journal-id><journal-title>BMC Veterinary Research</journal-title><issn pub-type="epub">1746-6148</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1746-6148-3-27</article-id><article-id pub-id-type="pmid">17937788</article-id><article-id pub-id-type="doi">10.1186/1746-6148-3-27</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The wild boar (<italic>Sus scrofa</italic>) Lymphocyte function-associated antigen-1 (CD11a/CD18) receptor: cDNA sequencing, structure analysis and comparison with homologues</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Bergh</surname><given-names>Philippe GAC Vanden</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>pvdbergh@student.ulg.ac.be</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Zecchinon</surname><given-names>Laurent LM</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>lzecchinon@ulg.ac.be</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Fett</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>thomas.fett@ulg.ac.be</email></contrib><contrib id="A4" corresp="yes" contrib-type="author"><name><surname>Desmecht</surname><given-names>Daniel JM</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>daniel.desmecht@ulg.ac.be</email></contrib></contrib-group><aff id="I1"><label>1</label>Pathology Department, Faculty of Veterinary Medicine, University of Liege, Colonster Boulevard 20 B43, B-4000 Liege, Belgium</aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>15</day><month>10</month><year>2007</year></pub-date><volume>3</volume><fpage>27</fpage><lpage>27</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1746-6148/3/27"/><history><date date-type="received"><day>3</day><month>5</month><year>2007</year></date><date date-type="accepted"><day>15</day><month>10</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Bergh et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Bergh et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Bergh GAC Vanden Philippe pvdbergh@student.ulg.ac.be </dc:author><dc:title> The wild boar (Sus scrofa) Lymphocyte function-associated antigen-1 (CD11a/CD18) receptor: cDNA sequencing, structure analysis and comparison with homologues </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Veterinary Research 3(1): 27-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1746-6148(2007)3:1&#x0003c;27&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1746-6148</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>The most predominant <italic>beta</italic>2-integrin lymphocyte function-associated antigen-1 (LFA-1, CD11a/CD18, <italic>alpha</italic>L<italic>beta</italic>2), expressed on all leukocytes, is essential for many adhesive functions of the immune system. Interestingly, RTX toxin-producing bacteria specifically target this leukocyte <italic>beta</italic>2-integrin which exacerbates lesions and disease development.</p></sec><sec><title>Results</title><p>This study reports the sequencing of the wild boar <italic>beta</italic>2-integrin CD11a and CD18 cDNAs. Predicted CD11a and CD18 subunits share all the main structural characteristics of their mammalian homologues, with a larger interspecies conservation for the CD18 than the CD11a. Besides these strong overall similarities, wild boar and domestic pig LFA-1 differ by 2 (CD18) and 1 or 3 (CD11a) substitutions, of which one is located in the crucial I-domain (CD11a, E168D).</p></sec><sec><title>Conclusion</title><p>As most wild boars are seropositive to the RTX toxin-producing bacterium <italic>Actinobacillus pleuropneumoniae </italic>and because they have sustained continuous natural selection, future studies addressing the functional impact of these polymorphisms could bring interesting new information on the physiopathology of <italic>Actinobacillus pleuropneumoniae-</italic>associated pneumonia in domestic pigs.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Cell adhesion receptors play crucial roles in multicellular organisms by mediating the direct cell/cell or cells/extracellular matrix proteins interactions. These molecular interactions condition the structural integrity of cells and tissues and contribute to the signalling transduction intervening in the cellular dynamic [<xref ref-type="bibr" rid="B1">1</xref>]. Cell adhesion receptors are subdivided in several membrane-associated protein families, including integrins, cadherins, immunoglobulin superfamily cell adhesion molecules, selectins, and syndecans. Integrins are a family of cell surface adhesion and signalling glycoproteins made up of non-covalently associated 120&#x02013;180 kDa <italic>&#x003b1; </italic>and 90-110kDa <italic>&#x003b2; </italic>subunits [<xref ref-type="bibr" rid="B2">2</xref>]. There are 19 distinct <italic>&#x003b1; </italic>subunits and 8 <italic>&#x003b2; </italic>subunits that are combined to form 25 different heterodimeric receptors [<xref ref-type="bibr" rid="B1">1</xref>]. Each subunit possesses (i) a large extracellular N-terminal domain associating with that of the companion subunit to form the integrin headpiece which contains the ligand binding site, (ii) a single transmembrane stretch, and (iii) a short cytoplasmic C-terminal tail which mediates interactions with cytoskeleton and signalling proteins [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>].</p><p>Within the integrin family, the leukocyte-specific <italic>&#x003b2;</italic><sub>2</sub>-integrins (CD11/CD18) include four members sharing in common the <italic>&#x003b2;</italic><sub>2 </sub>subunit (CD18) [<xref ref-type="bibr" rid="B5">5</xref>]: (i) the most predominant is the lymphocyte function-associated antigen-1 (LFA-1, CD11a/CD18, <italic>&#x003b1;</italic><sub>L</sub><italic>&#x003b2;</italic><sub>2</sub>) on all leukocytes [<xref ref-type="bibr" rid="B6">6</xref>]; (ii) the CD11b/CD18 (Mac-1, CR3, <italic>&#x003b1;</italic><sub>M</sub><italic>&#x003b2;</italic><sub>2</sub>) mainly on activated granulocytes and tissues macrophages [<xref ref-type="bibr" rid="B7">7</xref>]; (iii) the CD11c/CD18 (gp150/95, CR4, <italic>&#x003b1;</italic><sub>X</sub><italic>&#x003b2;</italic><sub>2</sub>, Leu-M5) also on activated granulocytes and tissues macrophages [<xref ref-type="bibr" rid="B8">8</xref>], and (iv) the CD11d/CD18 (<italic>&#x003b1;</italic><sub>D</sub><italic>&#x003b2;</italic><sub>2</sub>) abundant on the CD8+ lymphocyte and on macrophages [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>]. These receptors are essential for an effective immune system as observed in repeated infections associated with the lymphocyte adhesion deficiency (LAD) type I syndrome, a disease due to mutations in the <italic>&#x003b2;</italic><sub>2 </sub>(CD18) subunit gene leading to the lack of functional <italic>&#x003b2;</italic><sub>2 </sub>integrins on the membrane surface of leukocytes [<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B14">14</xref>].</p><p>The <italic>&#x003b2;</italic><sub>2</sub>-integrin LFA-1 is essential for the following functions of the immune system [<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B20">20</xref>] : (i) interaction between lymphocytes, (ii) interaction between T-cells and antigen presenting cells, (iii) adhesion of na&#x000ef;ve lymphocytes to post-capillary high endothelial venules of secondary lymphoid tissues, (iv) adhesion of leukocytes to activated endothelium at sites of inflammation for extravasation, (v) control of cell differentiation and proliferation, and (vi) antibody-dependent killing by natural killer cells and granulocytes. Leukocyte LFA-1-mediated adhesion is engaged via the binding of the LFA-1 in an activated conformational state to membrane proteins, the so-called intercellular adhesion molecules (ICAM)-1 to -5 and the junctional adhesion molecule (JAM)-A [<xref ref-type="bibr" rid="B21">21</xref>].</p><p>Interestingly, several pathogens target the leukocytes <italic>&#x003b2;</italic><sub>2</sub>-integrins which leads to lesions and disease development [<xref ref-type="bibr" rid="B22">22</xref>]. Several studies have highlighted the central role of LFA-1 in the pathogenesis of diseases caused by repeats-in-toxin (RTX)-producing bacteria. The virulence of <italic>Aggregatibacter </italic>(<italic>Actinobacillus</italic>) <italic>actinomycetemcomitans </italic>(localised aggressive periodontitis in humans), <italic>Mannheimia haemolytica </italic>(pneumonia in cattle), and pathogenic strains of <italic>Escherichia coli </italic>(extraintestinal infections) has been associated with a ligand/receptor interaction between their respective RTX toxin (LtxA, LktA, and HlyA) and the CD11a/CD18 receptor resulting in leukocytes alterations [<xref ref-type="bibr" rid="B23">23</xref>-<xref ref-type="bibr" rid="B26">26</xref>]. This interaction triggers synthesis and release of a wide array of cytokines and chemoattractants by the leukocytes that exacerbate inflammation and ultimately results in a much greater leukolysis worsening the lesions [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. <italic>Actinobacillus pleuropneumoniae</italic>, a causative agent of pleuropneumonia in domestic pigs (<italic>Sus scrofa domestica</italic>), responsible for economic losses and antibiotic usage in the pork industry, also produces RTX toxins (ApxIA, -IIA, -IIIA, and -IVA) [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. We therefore hypothesize that the pathogenesis of this disease similarly relies on an interaction with the <italic>Sus scrofa domestica </italic>LFA-1, whose CD11a (<italic>&#x003b1;</italic><sub>L</sub>) and CD18 (<italic>&#x003b2;</italic><sub>2</sub>) subunits have been well characterised [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. On the basis of the report that approximately 50% of wild boars in their natural environment are serologically positive for <italic>Actinobacillus pleuropneumoniae </italic>[<xref ref-type="bibr" rid="B32">32</xref>] and because these wild pigs sustain losses due to natural selection pressure, we hypothesize that some LFA-1 molecular peculiarities conferring resistance to wild boars could have been selected. In this context, the purpose of this study was to report the sequence and analysis of the cDNAs encoding wild boar LFA-1 (WbCD11a/WbCD18) and to point out the wild boar LFA-1 specificities that might confer resistance to <italic>Actinobacillus pleuropneumoniae</italic>-associated pneumonia.</p></sec><sec><title>Results and discussion</title><sec><title>Characterization of WbCD11a-encoding cDNA and deduced amino-acid sequence</title><p>The WbCD11a cDNA sequence contains an ORF of 3519 bp [GenBank:<ext-link ext-link-type="gen" xlink:href="EF585976">EF585976</ext-link>] that codes for 1172 aa (Fig. <xref ref-type="fig" rid="F1">1</xref>). Starting from the N-terminal end, the 1172 aa mature WbCD11a contains a 23-residue putative leader peptide (M<sub>1</sub>-S<sub>23</sub>), an extracellular domain of 1064 residues (Y<sub>24</sub>-D<sub>1086</sub>), a single hydrophobic transmembrane region of 24 residues (M<sub>1087</sub>-Y<sub>1110</sub>) and a short cytoplasmic tail of 62 residues (K<sub>1111</sub>-A<sub>1172</sub>) (Fig. <xref ref-type="fig" rid="F1">1</xref>). Six N-linked putative glycosylation sites (Asn-Xaa-Ser/Thr) are found in the extracellular domain (Fig. <xref ref-type="fig" rid="F1">1</xref>). The WbCD11a possesses 22 cysteine residues, among which one is located in the cytoplasmic tail (Fig. <xref ref-type="fig" rid="F1">1</xref>). A subset of integrin <italic>&#x003b1; </italic>chains (<italic>&#x003b1;</italic><sub>1</sub>, <italic>&#x003b1;</italic><sub>2</sub>, <italic>&#x003b1;</italic><sub>10</sub>, <italic>&#x003b1;</italic><sub>11</sub>, <italic>&#x003b1;</italic><sub>D</sub>, <italic>&#x003b1;</italic><sub>E</sub>, <italic>&#x003b1;</italic><sub>L</sub>, <italic>&#x003b1;</italic><sub>M </sub>and <italic>&#x003b1;</italic><sub>X</sub>), including CD11a, contains a I-domain (for <underline>I</underline>nserted domain, also called <italic>&#x003b1;</italic><sub>L</sub>I-domain or <italic>&#x003b1;</italic><sub>L</sub>A-domain) that is homologous to the family of von Willebrand Factor (vWF) A-type domains and to cartilage matrix protein [<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B34">34</xref>]. The I-domain has been associated with ligand binding. Its three-dimensional structure consists of a five-stranded parallel <italic>&#x003b2;</italic>-sheet core surrounded on both faces by seven <italic>&#x003b1;</italic>-helices (Fig. <xref ref-type="fig" rid="F1">1</xref>). A short antiparallel strand occurs on one edge of this sheet [<xref ref-type="bibr" rid="B35">35</xref>]. The I-domain (I<sub>149</sub>-D<sub>331</sub>) contains a metal ion-dependent adhesion site (MIDAS) (residues D<sub>160</sub>-S<sub>164</sub>, T<sub>229</sub>, D<sub>262</sub>) [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>] (Fig. <xref ref-type="fig" rid="F1">1</xref>). The I-domain crystallisation has demonstrated that a "closed" (low affinity) and an "open" (high affinity) forms exist and that the major conformational changes during transition from the closed to open states include a rearrangement of the cation-coordinating residues in the MIDAS site, accompanied by a small inward movement of the <italic>&#x003b1;</italic>1 helix and a large downward shift of the mobile C-terminal <italic>&#x003b1;</italic>7 helix [<xref ref-type="bibr" rid="B37">37</xref>]. The extracellular domain of WbCD11a contains seven internal repeats (FG-GAP) (G<sub>40</sub>-T<sub>89</sub>, S<sub>90</sub>-E<sub>147</sub>, S<sub>348</sub>-R<sub>398</sub>, A<sub>399</sub>-Q<sub>453</sub>, G<sub>455</sub>-D<sub>511</sub>, G<sub>513</sub>-F<sub>573</sub>, I<sub>576</sub>-P<sub>628</sub>) that surround the I-domain (Fig. <xref ref-type="fig" rid="F1">1</xref>) [<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref>]. The degree of identity is highest among the three COOH-terminal repeats (18&#x02013;31%) and their central region (D<sub>466</sub>-E<sub>474</sub>, D<sub>528</sub>-D<sub>536 </sub>and D<sub>588</sub>-D<sub>596</sub>) is similar to the EF hand divalent cation-binding motifs (DCBM) of troponin C, parvalbumin and galactose binding protein [<xref ref-type="bibr" rid="B38">38</xref>] (Fig. <xref ref-type="fig" rid="F1">1</xref>). All the cysteine residues and all but one N-glycosylation sites are found outside the I-region and divalent cation binding motifs (Fig. <xref ref-type="fig" rid="F1">1</xref>), consistent with the hypothesis that these regions may undergo conformational changes important in ligand binding [<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B40">40</xref>]. Between the FG-GAP 7 and the transmembrane domain stands the thigh domain (M<sub>629</sub>-K<sub>766</sub>), the genu (N<sub>767</sub>-C<sub>774</sub>), and the CALF domains (E<sub>775</sub>-L<sub>920</sub>, N<sub>921</sub>-D<sub>1086</sub>) [<xref ref-type="bibr" rid="B41">41</xref>]. The cytoplasmic portion of WbCD11a contains four potential phosphorylation sites and also a conserved "G<sub>1113</sub>FFKR" basic sequence near the transmembrane region (Fig. <xref ref-type="fig" rid="F1">1</xref>). The integrins become constitutively active when this sequence is deleted. The "G<sub>1113</sub>FFKR" motif thus normally fixes the integrins in an inactive state [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B42">42</xref>].</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>The nucleotide and deduced amino acid sequences of wild boar CD11a cDNA.</p></caption><graphic xlink:href="1746-6148-3-27-1"/></fig><p>Beside the complex mechanisms of affinity/avidity regulation of the integrins, the existence of several isoforms issued from alternative splicing complicates the biological understanding of these glycoproteins [<xref ref-type="bibr" rid="B43">43</xref>]. Previously, we have characterised two different forms of PoCD11a due to the presence of a supplementary "cag" codon that codes for a glutamine (Q) in position 744 [GenBank:<ext-link ext-link-type="gen" xlink:href="DQ013284">DQ013284</ext-link>, GenBank:<ext-link ext-link-type="gen" xlink:href="DQ013285">DQ013285</ext-link>] [<xref ref-type="bibr" rid="B31">31</xref>]. The addition of a Gln at the same position was also observed in the human (Q<sub>746</sub>) [GenBank:<ext-link ext-link-type="gen" xlink:href="NM_002209">NM_002209</ext-link>, GenBank:<ext-link ext-link-type="gen" xlink:href="AY892236">AY892236</ext-link>], the simian (Q<sub>746</sub>) [<xref ref-type="bibr" rid="B44">44</xref>], ovine (Q<sub>743</sub>) [<xref ref-type="bibr" rid="B45">45</xref>] and caprine (Q<sub>743</sub>) [GenBank:<ext-link ext-link-type="gen" xlink:href="AY773018">AY773018</ext-link>, GenBank:<ext-link ext-link-type="gen" xlink:href="AY773019">AY773019</ext-link>] CD11a cDNAs (Fig. <xref ref-type="fig" rid="F2">2</xref>). This addition located in the thigh domain of the extracellular part of CD11a, just above the genu, increases the length of an <italic>&#x003b1;</italic>-helix in the PoCD11a according to the GORIV bioinformatic program. Until now, it was not clear whether this addition represented two alleles or was generated by an alternative splicing. We have recently cloned and sequenced a third PoCD11a form characterised by an insertion of 27 amino acids at the same position (P<sub>744</sub>EPLQLSSTSSAASATLSRLPLLCAQ<bold><underline>Q</underline></bold><sub>770</sub>) [GenBank:<ext-link ext-link-type="gen" xlink:href="DQ474234">DQ474234</ext-link>] which is predicted to lengthen the <italic>&#x003b1;</italic>-helix further. The nucleotidic sequence of this insertion corresponds to that of the 3'end of the adjacent bovine and human intron 18 (79% and 70% of identity respectively), suggesting that the insertion of the glutamine or of the 27 amino acids-long stretch in position 744 of the thigh domain comes from an alternative splicing rather than from different alleles. Although these two insertions were not observed in the WbCD11a yet and because of the between-species conservation of this potential alternative splicing site, we hypothesize that it can have a biological importance for the mature CD11a, for example, in regulating the ligand binding and signaling activity.</p><fig position="float" id="F2"><label>Figure 2</label><caption><p>Comparison of the wild boar (Wb-), porcine (Po-), bovine (Bo-), ovine (Ov-), caprine (Cap-), human (Hu-), simian (Si-), canine (Can-), rat (Ra-) and murine (Mu-) &#x003b1;<sub>L </sub>subunits amino acids sequences.</p></caption><graphic xlink:href="1746-6148-3-27-2"/></fig></sec><sec><title>WbCD11a comparison among species</title><p>Overall, the general organization of wild boar (<italic>Sus scrofa</italic>), porcine (<italic>Sus scrofa domestica</italic>) [<xref ref-type="bibr" rid="B31">31</xref>], bovine (<italic>Bos taurus</italic>) [<xref ref-type="bibr" rid="B46">46</xref>], ovine (<italic>Ovis aries</italic>) [<xref ref-type="bibr" rid="B45">45</xref>], caprine (<italic>Capra hircus</italic>) [<xref ref-type="bibr" rid="B47">47</xref>], human [<xref ref-type="bibr" rid="B38">38</xref>], simian (<italic>Pan troglodytes</italic>) [<xref ref-type="bibr" rid="B44">44</xref>], canine (<italic>Canis familiaris</italic>) [GenBank:<ext-link ext-link-type="gen" xlink:href="XM_547024">XM_547024</ext-link>], rat (<italic>Rattus norvegicus</italic>) [GenBank:<ext-link ext-link-type="gen" xlink:href="NP_001029170">NP_001029170</ext-link>], and murine (<italic>Mus musculus</italic>) [<xref ref-type="bibr" rid="B48">48</xref>] CD11a proteins is quite similar (Fig. <xref ref-type="fig" rid="F2">2</xref>). Comparison between mature WbCD11a sequence and its porcine, bovine, ovine, caprine, human, simian, canine, rat and murine counterparts shows respectively overall 99%, 77%, 77%, 77%, 76%, 76%, 76%, 70% and 69% identity, and 99%, 87%, 86%, 86%, 86%, 86%, 85%, 81%, and 80% similarity (BLOSUM62table) (Table <xref ref-type="table" rid="T1">1</xref>). The highest identity is found for the "G<sub>1113</sub>FFKR" motif, the genu, the MIDAS motif and the transmembrane region and the lowest for the cytoplasmic tail and the putative signal peptide (Table <xref ref-type="table" rid="T1">1</xref>). Although DCBM3 presents a weak identity, its similarity score is high. The "G<sub>1113</sub>FFKR" sequence is highly conserved which is consistent with the stabilizing role of this motif for the <italic>alpha</italic>/<italic>beta </italic>complex, possibly because of its direct involvement in heterodimer formation [<xref ref-type="bibr" rid="B42">42</xref>]. The genu seems to play a key role in the activation of the LFA-1 through the deployment of the receptor [<xref ref-type="bibr" rid="B41">41</xref>] and its great conservation is therefore not surprising. The high conservation of the MIDAS and the putative cation binding motifs is consistent with an involvement of these regions in the functional activity of the LFA-1 <italic>&#x003b1; </italic>subunit, as suggested by the requirement of Mg<sup>2+ </sup>and Ca<sup>2+ </sup>for CD11a/CD18-dependent cellular interactions [<xref ref-type="bibr" rid="B40">40</xref>] or binding to purified ICAM-1 [<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B50">50</xref>]. The transmembrane region also shows a high degree of conservation, probably due to shared physicochemical and functional constraints. Indeed, residues lying in the membrane first have to possess a hydrophobic character to warrant liposolubility, which is confirmed by the presence of many leucine residues (Fig. <xref ref-type="fig" rid="F2">2</xref>). Secondly, bidirectional integrin signalling (inside-out and outside-in) is accomplished by transmission of information across the plasma membrane [<xref ref-type="bibr" rid="B51">51</xref>]. By contrast, the low conservation of the COOH-terminal part of the cytoplasmic tail suggests that it is not required to guarantee adequate functioning of LFA-1. This is in agreement with the observation that truncation of the LFA-1 <italic>&#x003b1; </italic>subunit cytoplasmic domain has no effect on binding to ICAM-1, whereas binding is markedly diminished by <italic>&#x003b2; </italic>subunit cytoplasmic domain truncation [<xref ref-type="bibr" rid="B52">52</xref>]. The "I<sub>149</sub>KGN" motif known to participate in the binding to ICAM-3 [<xref ref-type="bibr" rid="B53">53</xref>] shows a high degree of conservation (Fig. <xref ref-type="fig" rid="F2">2</xref>). The amino acid P<sub>215</sub>, participating to the binding to ICAM-1 [<xref ref-type="bibr" rid="B36">36</xref>] is highly conserved too (Fig. <xref ref-type="fig" rid="F2">2</xref>). Residue E<sub>333</sub>, located in the linker following the I domain which is critical for communication with the <italic>&#x003b2;</italic><sub>2 </sub>I-like domain, rolling, integrin extension and activation by Mn<sup>2+ </sup>[<xref ref-type="bibr" rid="B16">16</xref>] is logically strictly conserved too. The K<sub>1120 </sub>residue, critical for Rap1-dependent LFA-1 activation and affinity up-regulation [<xref ref-type="bibr" rid="B5">5</xref>] is also strongly conserved (Fig. <xref ref-type="fig" rid="F2">2</xref>). Every cysteine residue in the mature WbCD11a is present at the same location in bovine, ovine, human, simian, and murine CD11a, which is consistent with a role in maintaining the global structure of the protein. Finally, of six potential Asn-glycosylation sites in WbCD11a, the ones present at amino acids 186 and 724 are strictly conserved (Fig. <xref ref-type="fig" rid="F2">2</xref>). In addition, although WbCD11a sequences were obtained from only four wild boars, one of them was heterozygous. Both alleles differed from those found in pigs by a G736A substitution. One allele displayed 2 additional substitutions compared to pigs: E168D (in the I-domain) and D621E (in the FG-GAP7, Fig. <xref ref-type="fig" rid="F1">1</xref>). According to the BLOSUM 62 table, these substitutions are theoretically predicted to have a weak impact on the general structure of CD11a. However, these two wild boar-specific CD11a isoforms might display an altered/improved function compared to those described among domestic pigs [<xref ref-type="bibr" rid="B45">45</xref>].</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Between-species percent identities and similarities of CD11a constitutive blocks</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Block</bold></td><td align="center"><bold>Wb vs. Po</bold><break/><bold>(%)</bold><break/></td><td align="center"><bold>Wb vs. Bo</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Ov</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Cap</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Hu</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Si</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Can</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Ra</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Mu</bold><break/><bold>(%)</bold></td></tr></thead><tbody><tr><td align="left"><bold>Overall</bold></td><td align="center">99%<sup>(1)</sup><break/>99%<sup>(2)</sup></td><td align="center">77%<break/>87%</td><td align="center">77%<break/>86%</td><td align="center">77%<break/>86%</td><td align="center">76%<break/>86%</td><td align="center">76%<break/>86%</td><td align="center">76%<break/>85%</td><td align="center">70%<break/>81%</td><td align="center">69%<break/>80%</td></tr><tr><td colspan="10"><hr></hr></td></tr><tr><td align="left">Putative signal peptide</td><td align="center">100%<break/>100%</td><td align="center">86%<break/>95%</td><td align="center">78%<break/>86%</td><td align="center">78%<break/>86%</td><td align="center">82%<break/>91%</td><td align="center">56%<break/>68%</td><td align="center">69%<break/>73%</td><td align="center">50%<break/>54%</td><td align="center">54%<break/>58%</td></tr><tr><td colspan="10"><hr></hr></td></tr><tr><td align="left">Extracellular domain</td><td align="center">99%<break/>99%</td><td align="center">79%<break/>87%</td><td align="center">78%<break/>87%</td><td align="center">78%<break/>87%</td><td align="center">78%<break/>87%</td><td align="center">78%<break/>87%</td><td align="center">77%<break/>87%</td><td align="center">72%<break/>82%</td><td align="center">71%<break/>82%</td></tr><tr><td align="left">&#x02003;FG-GAP 1</td><td align="center">100%<break/>100%</td><td align="center">80%<break/>86%</td><td align="center">74%<break/>82%</td><td align="center">74%<break/>82%</td><td align="center">80%<break/>84%</td><td align="center">80%<break/>84%</td><td align="center">76%<break/>86%</td><td align="center">66%<break/>80%</td><td align="center">56%<break/>76%</td></tr><tr><td align="left">&#x02003;FG-GAP 2</td><td align="center">100%<break/>100%</td><td align="center">86%<break/>93%</td><td align="center">86%<break/>91%</td><td align="center">86%<break/>91%</td><td align="center">84%<break/>89%</td><td align="center">84%<break/>89%</td><td align="center">84%<break/>87%</td><td align="center">77%<break/>81%</td><td align="center">81%<break/>82%</td></tr><tr><td align="left">&#x02003;I-domain</td><td align="center">99%<break/>100%</td><td align="center">82%<break/>89%</td><td align="center">82%<break/>90%</td><td align="center">82%<break/>90%</td><td align="center">80%<break/>90%</td><td align="center">80%<break/>90%</td><td align="center">82%<break/>87%</td><td align="center">75%<break/>85%</td><td align="center">72%<break/>85%</td></tr><tr><td align="left">&#x02003;&#x02003;MIDAS</td><td align="center">100%<break/>100%</td><td align="center">85%<break/>85%</td><td align="center">85%<break/>85%</td><td align="center">85%<break/>85%</td><td align="center">85%<break/>85%</td><td align="center">85%<break/>85%</td><td align="center">85%<break/>85%</td><td align="center">85%<break/>85%</td><td align="center">85%<break/>85%</td></tr><tr><td align="left">&#x02003;FG-GAP 3</td><td align="center">100%<break/>100%</td><td align="center">82%<break/>90%</td><td align="center">80%<break/>86%</td><td align="center">82%<break/>88%</td><td align="center">86%<break/>94%</td><td align="center">86%<break/>94%</td><td align="center">78%<break/>86%</td><td align="center">76%<break/>84%</td><td align="center">80%<break/>88%</td></tr><tr><td align="left">&#x02003;FG-GAP 4</td><td align="center">100%<break/>100%</td><td align="center">85%<break/>90%</td><td align="center">83%<break/>87%</td><td align="center">85%<break/>89%</td><td align="center">74%<break/>83%</td><td align="center">76%<break/>83%</td><td align="center">80%<break/>85%</td><td align="center">72%<break/>78%</td><td align="center">70%<break/>78%</td></tr><tr><td align="left">&#x02003;FG-GAP 5</td><td align="center">100%<break/>100%</td><td align="center">78%<break/>93%</td><td align="center">76%<break/>91%</td><td align="center">76%<break/>91%</td><td align="center">83%<break/>95%</td><td align="center">83%<break/>95%</td><td align="center">83%<break/>95%</td><td align="center">80%<break/>91%</td><td align="center">80%<break/>90%</td></tr><tr><td align="left">&#x02003;&#x02003;DCBM 1</td><td align="center">100%<break/>100%</td><td align="center">66%<break/>100%</td><td align="center">66%<break/>100%</td><td align="center">66%<break/>100%</td><td align="center">77%<break/>100%</td><td align="center">77%<break/>100%</td><td align="center">77%<break/>100%</td><td align="center">77%<break/>100%</td><td align="center">77%<break/>88%</td></tr><tr><td align="left">&#x02003;FG-GAP 6</td><td align="center">100%<break/>100%</td><td align="center">82%<break/>86%</td><td align="center">81%<break/>86%</td><td align="center">82%<break/>86%</td><td align="center">79%<break/>86%</td><td align="center">77%<break/>86%</td><td align="center">81%<break/>87%</td><td align="center">81%<break/>89%</td><td align="center">87%<break/>91%</td></tr><tr><td align="left">&#x02003;&#x02003;DCBM 2</td><td align="center">100%<break/>100%</td><td align="center">77%<break/>88%</td><td align="center">77%<break/>88%</td><td align="center">77%<break/>88%</td><td align="center">77%<break/>88%</td><td align="center">77%<break/>88%</td><td align="center">77%<break/>88%</td><td align="center">88%<break/>100%</td><td align="center">77%<break/>88%</td></tr><tr><td align="left">&#x02003;FG-GAP 7</td><td align="center">98%<break/>100%</td><td align="center">90%<break/>96%</td><td align="center">90%<break/>96%</td><td align="center">90%<break/>96%</td><td align="center">83%<break/>90%</td><td align="center">83%<break/>90%</td><td align="center">90%<break/>92%</td><td align="center">84%<break/>88%</td><td align="center">81%<break/>88%</td></tr><tr><td align="left">&#x02003;&#x02003;DCBM 3</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">88%<break/>88%</td><td align="center">100%<break/>100%</td><td align="center">88%<break/>88%</td><td align="center">88%<break/>88%</td><td align="center">88%<break/>88%</td></tr><tr><td align="left">&#x02003;Thigh domain</td><td align="center">98%<break/>98%</td><td align="center">80%<break/>87%</td><td align="center">79%<break/>87%</td><td align="center">79%<break/>87%</td><td align="center">79%<break/>84%</td><td align="center">79%<break/>84%</td><td align="center">74%<break/>84%</td><td align="center">71%<break/>84%</td><td align="center">67%<break/>81%</td></tr><tr><td align="left">&#x02003;Genu</td><td align="center">100%<break/>100%</td><td align="center">87%<break/>87%</td><td align="center">87%<break/>87%</td><td align="center">87%<break/>87%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td></tr><tr><td align="left">&#x02003;CALF 1</td><td align="center">100%<break/>100%</td><td align="center">67%<break/>83%</td><td align="center">67%<break/>81%</td><td align="center">67%<break/>81%</td><td align="center">67%<break/>80%</td><td align="center">67%<break/>81%</td><td align="center">67%<break/>79%</td><td align="center">61%<break/>73%</td><td align="center">62%<break/>73%</td></tr><tr><td align="left">&#x02003;CALF 2</td><td align="center">100%<break/>100%</td><td align="center">71%<break/>81%</td><td align="center">72%<break/>83%</td><td align="center">71%<break/>81%</td><td align="center">77%<break/>89%</td><td align="center">77%<break/>89%</td><td align="center">71%<break/>88%</td><td align="center">68%<break/>83%</td><td align="center">69%<break/>83%</td></tr><tr><td colspan="10"><hr></hr></td></tr><tr><td align="left">Transmembrane region</td><td align="center">100%<break/>100%</td><td align="center">83%<break/>91%</td><td align="center">87%<break/>91%</td><td align="center">87%<break/>91%</td><td align="center">91%<break/>95%</td><td align="center">91%<break/>95%</td><td align="center">79%<break/>91%</td><td align="center">83%<break/>87%</td><td align="center">75%<break/>91%</td></tr><tr><td colspan="10"><hr></hr></td></tr><tr><td align="left">Cytoplasmic tail</td><td align="center">100%<break/>100%</td><td align="center">50%<break/>69%</td><td align="center">50%<break/>70%</td><td align="center">50%<break/>69%</td><td align="center">51%<break/>64%</td><td align="center">51%<break/>64%</td><td align="center">54%<break/>67%</td><td align="center">42%<break/>52%</td><td align="center">44%<break/>52%</td></tr><tr><td align="left">&#x02003;"GFFKR" motif</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td></tr></tbody></table><table-wrap-foot><p>Wb, Po, Bo, Ov, Cap, Hu, Si, Can, Ra, and Mu: wild boar, porcine, bovine, ovine, caprine, human, simian, canine, rat, and murine CD11a, respectively ; FG-GAP : &#x003b2;-propeller repeat; MIDAS: metal-ion dependent adhesion site ; DCBM : divalent-cation binding motif ; vs : versus. (1) identity; (2) similarity (BLOSUM62 table).</p></table-wrap-foot></table-wrap></sec><sec><title>Characterization of WbCD18-encoding cDNA and deduced amino-acid sequence</title><p>The cDNA sequence of WbCD18 contains an ORF of 2310 bp [GenBank:<ext-link ext-link-type="gen" xlink:href="EF585977">EF585977</ext-link>] that codes for 769 aa (Fig. <xref ref-type="fig" rid="F3">3</xref>). The mature WbCD18 contains a 22 aa putative leader peptide (M<sub>1</sub>-S<sub>22</sub>), an extracellular domain of 679 residues (Q<sub>23</sub>-N<sub>700</sub>), a single hydrophobic transmembrane region of 23 residues (I<sub>701</sub>-W<sub>723</sub>) and a short cytoplasmic tail of 46 residues (K<sub>724</sub>-R<sub>769</sub>) (Fig. <xref ref-type="fig" rid="F3">3</xref>). Starting from the N-terminal end, the extracellular region successively contains a cysteine-rich repeats-containing analogue of the so-called [<xref ref-type="bibr" rid="B54">54</xref>] plexin-semaphorin integrin domain (Q<sub>23</sub>-V<sub>74</sub>) [<xref ref-type="bibr" rid="B55">55</xref>], a spacer (A<sub>75</sub>-K<sub>123</sub>) [<xref ref-type="bibr" rid="B55">55</xref>,<xref ref-type="bibr" rid="B56">56</xref>], an inserted I-like domain of 240 amino acids (G<sub>124</sub>-L<sub>363</sub>), a mid-region (S<sub>364</sub>-C<sub>445</sub>) that fold-up with the spacer to form the hybrid domain [<xref ref-type="bibr" rid="B55">55</xref>,<xref ref-type="bibr" rid="B56">56</xref>], a cysteine-rich region containing four EGF-like regions (C<sub>449</sub>-E<sub>482</sub>, C<sub>483</sub>-E<sub>535</sub>, C<sub>536</sub>-Q<sub>574</sub>, and C<sub>575</sub>-T<sub>613</sub>) [<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B55">55</xref>,<xref ref-type="bibr" rid="B57">57</xref>], and a C-terminal <italic>&#x003b2;</italic>-tail domain [<xref ref-type="bibr" rid="B5">5</xref>] (D<sub>614</sub>-N<sub>700</sub>) (Fig. <xref ref-type="fig" rid="F3">3</xref>). A putative metal ion-dependent adhesion site (MIDAS)-like DXSXS motif (D<sub>134</sub>-M<sub>139</sub>), an adjacent site to MIDAS (ADMIDAS) (D<sub>141</sub>, D<sub>142</sub>, E<sub>347</sub>), and a ligand-induced metal-binding site (LIMBS) (D<sub>173</sub>, N<sub>229</sub>, D<sub>231</sub>, P<sub>233</sub>, E<sub>234</sub>) motif are predicted within the I-like domain [<xref ref-type="bibr" rid="B58">58</xref>]. The cytoplasmic tail contains the binding sites for cytohesin, Rack1 (K<sub>724</sub>VLT), and <italic>&#x003b1;</italic>-actinin (K<sub>736</sub>RFEKEKLKSQ) [<xref ref-type="bibr" rid="B59">59</xref>]. Overall, the protein contains 58 cysteine residues and 5 N-linked putative glycosylation sites (Asn-X-Thr/Ser), all located within the extracellular region (Fig. <xref ref-type="fig" rid="F3">3</xref>).</p><fig position="float" id="F3"><label>Figure 3</label><caption><p>The nucleotide and deduced amino acid sequences of wild boar CD18 cDNA.</p></caption><graphic xlink:href="1746-6148-3-27-3"/></fig></sec><sec><title>WbCD18 comparison among species</title><p>Overall, the general organization of wild boar (<italic>Sus scrofa</italic>), porcine (<italic>Sus scrofa domestica</italic>) [<xref ref-type="bibr" rid="B30">30</xref>], bovine (<italic>Bos taurus</italic>) [<xref ref-type="bibr" rid="B60">60</xref>], water buffalo (<italic>Bubalus bubalis</italic>) (GenPept AAW29104), caprine (<italic>Capra hircus</italic>) [<xref ref-type="bibr" rid="B61">61</xref>], ovine (<italic>Ovis aries </italic>and <italic>Ovis canadensis</italic>) [<xref ref-type="bibr" rid="B62">62</xref>,<xref ref-type="bibr" rid="B63">63</xref>], human [<xref ref-type="bibr" rid="B64">64</xref>], canine (<italic>Canis familiaris</italic>) [<xref ref-type="bibr" rid="B65">65</xref>], murine (<italic>Mus musculus</italic>) [<xref ref-type="bibr" rid="B66">66</xref>], rat (<italic>Rattus norvegicus</italic>) [GenBank:<ext-link ext-link-type="gen" xlink:href="NM_001037780">NM_001037780</ext-link>], chicken (<italic>Gallus gallus</italic>) [<xref ref-type="bibr" rid="B67">67</xref>], carp and channel catfish (<italic>Cyprinus carpio </italic>and <italic>Ictalurus punctatus</italic>) [GenBank:<ext-link ext-link-type="gen" xlink:href="AB031070">AB031070</ext-link>] [<xref ref-type="bibr" rid="B68">68</xref>] CD18 proteins is quite similar (Fig. <xref ref-type="fig" rid="F4">4</xref>). Sequence comparisons between WbCD18 and its porcine, bovine, water buffalo, caprine, ovine, human, canine, murine, rat, chicken, carp and channel catfish counterparts shows respectively, 99%, 88%, 88%, 88%, 88%, 87%, 83%, 81%, 81%, 80%, 62%, 49% and 48% identity, and 99%, 93%, 93%, 93%, 93%, 93%, 90%, 89%, 88%, 88%, 76%, 64% and 63% similarity (BLOSUM62 table) (Table <xref ref-type="table" rid="T2">2</xref>). The MIDAS-like, ADMIDAS, LIMBS motifs, the I-like domain, the EGF-2 domain and the cytoplasmic tail have the highest identity while the putative peptide signal, the <italic>&#x003b2;</italic>-tail domain, and the EGF-1 show the lowest identity (Table <xref ref-type="table" rid="T2">2</xref>). The very high interspecies conservation of the putative MIDAS-like, ADMIDAS, LIMBS, I-like domains and the cytoplasmic tail is consistent with an involvement of these regions in the functional activities of <italic>&#x003b2;</italic><sub>2</sub>-integrins. Overall, the high evolutionary conservation of the I-like domain confirms its importance in <italic>&#x003b2;</italic><sub>2</sub>-integrins functions, which is compatible with the observation that monoclonal antibodies binding epitopes mapped within this region inhibit binding of LFA-1 to ICAMs 1&#x02013;3 [<xref ref-type="bibr" rid="B56">56</xref>]. The maximum conservation being observed for the CD18 MIDAS-like motif, it is tempting to speculate that it plays a fundamental role in <italic>&#x003b2;</italic><sub>2</sub>-integrin function. In this way, it was demonstrated that the C<sub>169</sub>PNKEKEC sequence conserved among mammalian species (Fig. <xref ref-type="fig" rid="F4">4</xref>) constitutively activates LFA-1 binding to ICAM-1 [<xref ref-type="bibr" rid="B69">69</xref>]. LIMBS and ADMIDAS sites modulate binding of ligand to the MIDAS-like in the integrins that lack the <italic>&#x003b1;</italic>I domain [<xref ref-type="bibr" rid="B70">70</xref>-<xref ref-type="bibr" rid="B72">72</xref>] but the ADMIDAS seems also to regulate <italic>&#x003b1;</italic><sub>L </sub>I domain affinity and to participate in the outside-in signalling [<xref ref-type="bibr" rid="B58">58</xref>]. The high degree of conservation in the cytoplasmic tail, with many Ser, Thr, and Tyr residues, is compatible with the important role that phosphorylation of these residues plays in regulating adhesive activity [<xref ref-type="bibr" rid="B73">73</xref>] and with the observation that cytoplasmic domain truncation of CD18 markedly diminishes binding of LFA-1 to ICAM-1 [<xref ref-type="bibr" rid="B52">52</xref>]. Importantly, it was shown that the phosphorylation of the highly conserved residues T<sub>758</sub>, T<sub>759 </sub>and T<sub>760 </sub>plays a crucial role in the activation of the receptor and the binding to ICAM-1 [<xref ref-type="bibr" rid="B59">59</xref>,<xref ref-type="bibr" rid="B74">74</xref>]. In addition, the key residue F766 for binding to ICAM-1 is strictly conserved [<xref ref-type="bibr" rid="B59">59</xref>]. Although EGF-1 possesses a weaker identity, its similarity is very high (Table <xref ref-type="table" rid="T2">2</xref>). The weaker conservation of the <italic>&#x003b2;</italic>-tail domain could translate a less degree of importance of this domain for the CD18 function. Every cysteine residue in the wild boar extracellular portion of mature CD18 is present at the same location in CD18 from other species, which is consistent with a role in maintaining the global structure of the protein. Similarly, all five potential Asn-glycosylation sites observed in wild boar are present at the same location in other mammalian species. Wild boar-specific CD18 isoform is characterized by two amino acid substitutions compared to domestic pigs: G560S and A721V, which should not result in structural differences, according to BLOSUM 62 table, but might impact CD18 function.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Between-species percent identities and similarities of CD18 constitutive blocks</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Block</bold></td><td align="center"><bold>Wb vs. Po</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Bo</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Bu</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Cap</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. OvAr</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. OvCan</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Hu</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Can</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Mu</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Ra</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Gal</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Cyp</bold><break/><bold>(%)</bold></td><td align="center"><bold>Wb vs. Ict</bold><break/><bold>(%)</bold></td></tr></thead><tbody><tr><td align="left"><bold>Overall</bold></td><td align="center">99%<sup>(1)</sup><break/>99%<sup>(2)</sup></td><td align="center">88%<break/>93%</td><td align="center">88%<break/>93%</td><td align="center">88%<break/>93%</td><td align="center">88%<break/>93%</td><td align="center">87%<break/>93%</td><td align="center">83%<break/>90%</td><td align="center">81%<break/>89%</td><td align="center">81%<break/>88%</td><td align="center">80%<break/>88%</td><td align="center">62%<break/>76%</td><td align="center">49%<break/>64%</td><td align="center">48%<break/>63%</td></tr><tr><td colspan="14"><hr></hr></td></tr><tr><td align="left">Putative signal peptide</td><td align="center">100%<break/>100%</td><td align="center">59%<break/>68%</td><td align="center">54%<break/>68%</td><td align="center">59%<break/>68%</td><td align="center">59%<break/>72%</td><td align="center">59%<break/>72%</td><td align="center">56%<break/>60%</td><td align="center">56%<break/>60%</td><td align="center">52%<break/>60%</td><td align="center">60%<break/>60%</td><td align="center">28%<break/>44%</td><td align="center">28%<break/>32%</td><td align="center">22%<break/>50%</td></tr><tr><td colspan="14"><hr></hr></td></tr><tr><td align="left">Extracellular domain</td><td align="center">99%<break/>99%</td><td align="center">88%<break/>94%</td><td align="center">89%<break/>94%</td><td align="center">89%<break/>94%</td><td align="center">88%<break/>94%</td><td align="center">88%<break/>93%</td><td align="center">84%<break/>91%</td><td align="center">82%<break/>91%</td><td align="center">81%<break/>89%</td><td align="center">80%<break/>88%</td><td align="center">63%<break/>77%</td><td align="center">50%<break/>64%</td><td align="center">48%<break/>63%</td></tr><tr><td align="left">&#x02003;PSI</td><td align="center">100%<break/>100%</td><td align="center">84%<break/>92%</td><td align="center">86%<break/>94%</td><td align="center">88%<break/>92%</td><td align="center">88%<break/>92%</td><td align="center">86%<break/>90%</td><td align="center">75%<break/>88%</td><td align="center">88%<break/>92%</td><td align="center">80%<break/>90%</td><td align="center">78%<break/>88%</td><td align="center">65%<break/>78%</td><td align="center">55%<break/>69%</td><td align="center">61%<break/>75%</td></tr><tr><td align="left">&#x02003;Spacer (Hybrid domain)</td><td align="center">100%<break/>100%</td><td align="center">77%<break/>91%</td><td align="center">79%<break/>91%</td><td align="center">77%<break/>93%</td><td align="center">77%<break/>93%</td><td align="center">77%<break/>93%</td><td align="center">89%<break/>93%</td><td align="center">83%<break/>93%</td><td align="center">79%<break/>87%</td><td align="center">67%<break/>79%</td><td align="center">38%<break/>56%</td><td align="center">25%<break/>42%</td><td align="center">30%<break/>50%</td></tr><tr><td align="left">&#x02003;I-like domain</td><td align="center">99%<break/>100%</td><td align="center">96%<break/>98%</td><td align="center">96%<break/>98%</td><td align="center">95%<break/>98%</td><td align="center">95%<break/>98%</td><td align="center">95%<break/>98%</td><td align="center">96%<break/>98%</td><td align="center">95%<break/>99%</td><td align="center">95%<break/>97%</td><td align="center">95%<break/>97%</td><td align="center">79%<break/>89%</td><td align="center">65%<break/>75%</td><td align="center">63%<break/>75%</td></tr><tr><td align="left">&#x02003;&#x02003;MIDAS</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td></tr><tr><td align="left">&#x02003;&#x02003;ADMIDAS</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">66%<break/>100%</td><td align="center">66%<break/>100%</td><td align="center">66%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">66%<break/>66%</td></tr><tr><td align="left">&#x02003;&#x02003;LIMBS</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td></tr><tr><td align="left">&#x02003;Mid-region (Hybrid domain)</td><td align="center">100%<break/>100%</td><td align="center">91%<break/>96%</td><td align="center">91%<break/>96%</td><td align="center">93%<break/>96%</td><td align="center">93%<break/>96%</td><td align="center">92%<break/>95%</td><td align="center">92%<break/>97%</td><td align="center">89%<break/>95%</td><td align="center">84%<break/>90%</td><td align="center">82%<break/>90%</td><td align="center">58%<break/>71%</td><td align="center">41%<break/>53%</td><td align="center">32%<break/>54%</td></tr><tr><td align="left">&#x02003;EGF-1</td><td align="center">97%<break/>100%</td><td align="center">73%<break/>91%</td><td align="center">70%<break/>91%</td><td align="center">76%<break/>94%</td><td align="center">73%<break/>94%</td><td align="center">70%<break/>91%</td><td align="center">67%<break/>82%</td><td align="center">61%<break/>79%</td><td align="center">70%<break/>88%</td><td align="center">67%<break/>85%</td><td align="center">35%<break/>52%</td><td align="center">47%<break/>64%</td><td align="center">30%<break/>52%</td></tr><tr><td align="left">&#x02003;EGF-2</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">100%<break/>100%</td><td align="center">98%<break/>100%</td><td align="center">98%<break/>100%</td><td align="center">98%<break/>100%</td><td align="center">88%<break/>96%</td><td align="center">81%<break/>94%</td><td align="center">88%<break/>98%</td><td align="center">88%<break/>98%</td><td align="center">79%<break/>94%</td><td align="center">41%<break/>58%</td><td align="center">41%<break/>50%</td></tr><tr><td align="left">&#x02003;EGF-3</td><td align="center">97%<break/>97%</td><td align="center">87%<break/>94%</td><td align="center">87%<break/>94%</td><td align="center">87%<break/>92%</td><td align="center">82%<break/>92%</td><td align="center">79%<break/>92%</td><td align="center">76%<break/>87%</td><td align="center">69%<break/>87%</td><td align="center">66%<break/>79%</td><td align="center">79%<break/>84%</td><td align="center">64%<break/>76%</td><td align="center">48%<break/>66%</td><td align="center">51%<break/>74%</td></tr><tr><td align="left">&#x02003;EGF-4</td><td align="center">100%<break/>100%</td><td align="center">92%<break/>94%</td><td align="center">92%<break/>94%</td><td align="center">92%<break/>92%</td><td align="center">92%<break/>92%</td><td align="center">92%<break/>92%</td><td align="center">69%<break/>82%</td><td align="center">76%<break/>92%</td><td align="center">66%<break/>76%</td><td align="center">69%<break/>79%</td><td align="center">61%<break/>66%</td><td align="center">43%<break/>58%</td><td align="center">38%<break/>48%</td></tr><tr><td align="left">&#x02003;&#x003b2;-tail domain</td><td align="center">100%<break/>100%</td><td align="center">74%<break/>81%</td><td align="center">74%<break/>81%</td><td align="center">73%<break/>80%</td><td align="center">73%<break/>80%</td><td align="center">73%<break/>80%</td><td align="center">57%<break/>71%</td><td align="center">54%<break/>65%</td><td align="center">56%<break/>69%</td><td align="center">56%<break/>70%</td><td align="center">42%<break/>64%</td><td align="center">39%<break/>52%</td><td align="center">39%<break/>56%</td></tr><tr><td colspan="14"><hr></hr></td></tr><tr><td align="left">Transmembrane region</td><td align="center">95%<break/>95%</td><td align="center">91%<break/>95%</td><td align="center">91%<break/>95%</td><td align="center">91%<break/>95%</td><td align="center">95%<break/>100%</td><td align="center">95%<break/>100%</td><td align="center">78%<break/>91%</td><td align="center">82%<break/>91%</td><td align="center">73%<break/>91%</td><td align="center">69%<break/>91%</td><td align="center">56%<break/>73%</td><td align="center">52%<break/>78%</td><td align="center">52%<break/>78%</td></tr><tr><td colspan="14"><hr></hr></td></tr><tr><td align="left">Cytoplasmic tail</td><td align="center">100%<break/>100%</td><td align="center">93%<break/>93%</td><td align="center">93%<break/>93%</td><td align="center">93%<break/>93%</td><td align="center">93%<break/>93%</td><td align="center">93%<break/>93%</td><td align="center">91%<break/>93%</td><td align="center">89%<break/>95%</td><td align="center">91%<break/>95%</td><td align="center">89%<break/>93%</td><td align="center">65%<break/>82%</td><td align="center">50%<break/>68%</td><td align="center">50%<break/>68%</td></tr><tr><td colspan="14"><hr></hr></td></tr><tr><td align="left">&#x02003;Cytohesin, Rack1 binding site</td><td align="center">100%<break/>100%</td><td align="center">75%<break/>75%</td><td align="center">75%<break/>75%</td><td align="center">75%<break/>75%</td><td align="center">75%<break/>75%</td><td align="center">75%<break/>75%</td><td align="center">50%<break/>50%</td><td align="center">75%<break/>75%</td><td align="center">75%<break/>75%</td><td align="center">75%<break/>75%</td><td align="center">50%<break/>100%</td><td align="center">25%<break/>50%</td><td align="center">50%<break/>50%</td></tr><tr><td align="left">&#x02003;&#x003b1;-actinin binding site</td><td align="center">100%<break/>100%</td><td align="center">90%<break/>90%</td><td align="center">90%<break/>90%</td><td align="center">90%<break/>90%</td><td align="center">90%<break/>90%</td><td align="center">90%<break/>90%</td><td align="center">90%<break/>100%</td><td align="center">90%<break/>100%</td><td align="center">90%<break/>100%</td><td align="center">90%<break/>100%</td><td align="center">63%<break/>90%</td><td align="center">45%<break/>72%</td><td align="center">54%<break/>72%</td></tr></tbody></table><table-wrap-foot><p>Wb, Po, Bo, Bu, Cap, OvAr, OvCa, Hu, Can, Mu, Ra, Gal, Cyp, and Ict: wild boar, porcine, bovine, water buffalo, caprine, ovine (<italic>ovis aries</italic>), ovine (<italic>ovis canadensis</italic>), human, canine, murine, rat, chicken, carp, and channel catfish CD18, respectively ; PSI : plexin-semaphorin integrin ; MIDAS: metal-ion dependent adhesion site ; ADMIDAS : adjacent to MIDAS ; LIMBS : ligand-induced metal-binding site ; EGF : epidermal growth factor site; vs : versus. (1) identity; (2) similarity (BLOSUM62 table).</p></table-wrap-foot></table-wrap><fig position="float" id="F4"><label>Figure 4</label><caption><p>Comparison of the wild boar (Wb-), porcine (Po-), bovine (Bo-), water buffalo (Bu-), caprine (Cap-), ovine (<italic>Ovis aries </italic>and <italic>canadensis</italic>) (OvAr- and OvCan-), human (Hu-), canine (Can-), murine (Mu-), rat (Ra-), chicken (Gal-), carp (Cyp-) and channel catfish (Ict-) &#x003b2;<sub>2 </sub>subunits amino acids sequences.</p></caption><graphic xlink:href="1746-6148-3-27-4"/></fig></sec></sec><sec><title>Conclusion</title><p>This study reports the sequencing of the wild boar <italic>&#x003b2;</italic><sub>2</sub>-integrin CD11a/CD18 subunits cDNAs. Predicted CD11a and CD18 subunits share all the main structural characteristics of their mammalian homologues, with a larger interspecies conservation for the CD18 than the CD11a. Besides these strong overall similarities, wild boar and domestic pig LFA-1 differ by 2 (CD18) and 1 or 3 (CD11a) substitutions, of which one is located in the crucial I-domain (CD11a, E168D). As most wild boars are seropositive to <italic>Actinobacillus pleuropneumoniae </italic>and because they have sustained continuous natural selection, future studies of the functional impact of these polymorphisms could bring interesting new information on the physiopathology of pneumonia in domestic pigs.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>RNA isolation</title><p>Total RNA from spleen of freshly slaughtered wild boars (<italic>Sus scrofa</italic>) was extracted with TRIzol (Invitrogen, USA) as described by the manufacturer.</p></sec><sec><title>Amplification and sequencing of the full length cDNA</title><p>Total RNA from spleen was reverse transcribed using Improm II (Promega). The full-length cDNA was then generated by long distance PCR using <italic>Taq </italic>and <italic>Pfu </italic>DNA polymerase from the High Fidelity PCR Enzyme Mix (Fermentas) with primers designed from the 5'- and 3'UTR of PoCD11a [<xref ref-type="bibr" rid="B31">31</xref>] and PoCD18 [<xref ref-type="bibr" rid="B30">30</xref>]. The couple of primers used for amplification of WbCD11a and WbCD18 are the next: 5'GGTATGGTCCCTCCAGAAGC-3' (CD11a forward), 5'-GCAGGCTGAGTCCAGTCCTG-3' (CD11a reverse), 5'-GAGGTCTCCAGGACATCAAG-3' (CD18 forward) and 5'-TAGGGGTGCTTGGTGAAGAC-3' (CD18 reverse). The procedures recommended by the manufacturer were applied, with the following cycling parameters : 5 min at 94&#x000b0;C, then 35 cycles including (i) 30 s at 94&#x000b0;C, (ii) 45 s at 60&#x000b0;C and (iii) 3 min 45 s at 72&#x000b0;C, and a final extension at 72&#x000b0;C for 10 min. Resulting PCR products were purified using the NucleoSpin<sup>&#x000ae;</sup>ExtractII kit (Macherey-Nagel), and sequenced on a ABI-3100 Genetic Analyzer using the Big Dye terminator chemistry (Applied Biosystems). The CD11a/CD18 cDNA sequences were deduced from sequences obtained from four independent wild boars. Sequences data have been deposited at GenBank under accession nos. <ext-link ext-link-type="gen" xlink:href="EF585976">EF585976</ext-link> and <ext-link ext-link-type="gen" xlink:href="EF585977">EF585977</ext-link>.</p></sec><sec><title>Bioinformatics</title><p>Primers design was performed with Netprimer [<xref ref-type="bibr" rid="B75">75</xref>] and Primer 3 [<xref ref-type="bibr" rid="B76">76</xref>]. Nucleotidic sequence and identity analyses were carried out using respectively Chromas v.2.21 [<xref ref-type="bibr" rid="B77">77</xref>] and BLAST programs [<xref ref-type="bibr" rid="B78">78</xref>]. Alignment of amino acids sequences was drawn by GeneDoc v.2.6.002 [<xref ref-type="bibr" rid="B79">79</xref>] following the BLOSUM 62 matrix. SignalP v.2.0.b2 [<xref ref-type="bibr" rid="B80">80</xref>] and NetNGlyc v.1.0 [<xref ref-type="bibr" rid="B81">81</xref>] provided peptide signal and N-glycosylation sites prediction, respectively. The secondary structures were resolved by the GOR secondary structure prediction method version IV [<xref ref-type="bibr" rid="B82">82</xref>].</p></sec></sec><sec><title>List of abbreviations</title><p>aa, amino acid ; ADMIDAS, adjacent to MIDAS ; Bo, bovine; Can, canine ; Cap, caprine ; CD, cluster of differentiation ; CR, complement receptor ; Cyp, <italic>Cyprinus </italic>; DCBM, divalent-cation binding motif ; EGF, epidermal growth factor ; Gal, <italic>Gallus </italic>; Hu, human; ICAM, intercellular adhesion molecule ; Ict, <italic>Ictalurus</italic>; LFA, lymphocyte function-associated antigen; LIMBS, ligand-induced metal-binding site; MIDAS, metal-ion dependent adhesion site; Mu, murine; Ov, ovine ; OvAr, <italic>Ovis aries </italic>; OvCan, <italic>Ovis Canadensis </italic>; Po, porcine ; Ra : rat ; PSI, plexin-semaphorin integrin ; Si : simian, Wb : wild boar.</p></sec><sec><title>Authors' contributions</title><p>PVB carried out amplification, sequencing, sequences alignment and drafting of the manuscript. TF and LZ participated in the design of the study and helped to structure analysis. DD participated in the design of the study and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>Philippe Vanden Bergh is the recipient of a studentship from the "Fonds pour la formation &#x000e0; la Recherche dans l'Industrie et l'Agriculture", rue d'Egmont 5, B-1000 Bruxelles.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hauck</surname><given-names>CR</given-names></name></person-group><article-title>Cell adhesion receptors - signaling capacity and exploitation by bacterial pathogens</article-title><source>Med Microbiol Immunol (Berl)</source><year>2002</year><volume>191</volume><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">12410343</pub-id><pub-id pub-id-type="doi">10.1007/s00430-002-0119-0</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hynes</surname><given-names>RO</given-names></name></person-group><article-title>Integrins: versatility, modulation, and signaling in cell adhesion</article-title><source>Cell</source><year>1992</year><volume>69</volume><fpage>11</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">1555235</pub-id><pub-id pub-id-type="doi">10.1016/0092-8674(92)90115-S</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dib</surname><given-names>K</given-names></name></person-group><article-title>BETA 2 integrin signaling in leukocytes</article-title><source>Front Biosci</source><year>2000</year><volume>5</volume><fpage>D438</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">10762594</pub-id><pub-id pub-id-type="doi">10.2741/Pathology</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Humphries</surname><given-names>MJ</given-names></name><name><surname>Symonds</surname><given-names>EJ</given-names></name><name><surname>Mould</surname><given-names>AP</given-names></name></person-group><article-title>Mapping functional residues onto integrin crystal structures</article-title><source>Curr Opin Struct Biol</source><year>2003</year><volume>13</volume><fpage>236</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">12727518</pub-id><pub-id pub-id-type="doi">10.1016/S0959-440X(03)00035-6</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zecchinon</surname><given-names>L</given-names></name><name><surname>Fett</surname><given-names>T</given-names></name><name><surname>Vanden Bergh</surname><given-names>P</given-names></name><name><surname>Desmecht</surname><given-names>D</given-names></name></person-group><article-title>Anatomy of the lymphocyte function-associated antigen-1</article-title><source>Clin Appl Immunol Rev</source><year>2006</year><volume>6</volume><fpage>149</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/j.cair.2006.09.002</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Springer</surname><given-names>TA</given-names></name><name><surname>Dustin</surname><given-names>ML</given-names></name><name><surname>Kishimoto</surname><given-names>TK</given-names></name><name><surname>Marlin</surname><given-names>SD</given-names></name></person-group><article-title>The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system</article-title><source>Annu Rev Immunol</source><year>1987</year><volume>5</volume><fpage>223</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">3109455</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Springer</surname><given-names>T</given-names></name><name><surname>Galfre</surname><given-names>G</given-names></name><name><surname>Secher</surname><given-names>DS</given-names></name><name><surname>Milstein</surname><given-names>C</given-names></name></person-group><article-title>Mac-1: a macrophage differentiation antigen identified by monoclonal antibody</article-title><source>Eur J Immunol</source><year>1979</year><volume>9</volume><fpage>301</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">89034</pub-id><pub-id pub-id-type="doi">10.1002/eji.1830090410</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cabanas</surname><given-names>C</given-names></name><name><surname>Sanchez-Madrid</surname><given-names>F</given-names></name></person-group><article-title>CD11c (leukocyte integrin CR4 alpha subunit)</article-title><source>J Biol Regul Homeost Agents</source><year>1999</year><volume>13</volume><fpage>134</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">10503738</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van der Vieren</surname><given-names>M</given-names></name><name><surname>Le Trong</surname><given-names>H</given-names></name><name><surname>Wood</surname><given-names>CL</given-names></name><name><surname>Moore</surname><given-names>PF</given-names></name><name><surname>St John</surname><given-names>T</given-names></name><name><surname>Staunton</surname><given-names>DE</given-names></name><name><surname>Gallatin</surname><given-names>WM</given-names></name></person-group><article-title>A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3</article-title><source>Immunity</source><year>1995</year><volume>3</volume><fpage>683</fpage><lpage>690</lpage><pub-id pub-id-type="pmid">8777714</pub-id><pub-id pub-id-type="doi">10.1016/1074-7613(95)90058-6</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Danilenko</surname><given-names>DM</given-names></name><name><surname>Rossitto</surname><given-names>PV</given-names></name><name><surname>Van der Vieren</surname><given-names>M</given-names></name><name><surname>Le Trong</surname><given-names>H</given-names></name><name><surname>McDonough</surname><given-names>SP</given-names></name><name><surname>Affolter</surname><given-names>VK</given-names></name><name><surname>Moore</surname><given-names>PF</given-names></name></person-group><article-title>A novel canine leukointegrin, alpha d beta 2, is expressed by specific macrophage subpopulations in tissue and a minor CD8+ lymphocyte subpopulation in peripheral blood</article-title><source>J Immunol</source><year>1995</year><volume>155</volume><fpage>35</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">7541420</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gahmberg</surname><given-names>CG</given-names></name><name><surname>Valmu</surname><given-names>L</given-names></name><name><surname>Fagerholm</surname><given-names>S</given-names></name><name><surname>Kotovuori</surname><given-names>P</given-names></name><name><surname>Ihanus</surname><given-names>E</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Pessa-Morikawa</surname><given-names>T</given-names></name></person-group><article-title>Leukocyte integrins and inflammation</article-title><source>Cell Mol Life Sci</source><year>1998</year><volume>54</volume><fpage>549</fpage><lpage>555</lpage><pub-id pub-id-type="pmid">9676574</pub-id><pub-id pub-id-type="doi">10.1007/s000180050183</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnaout</surname><given-names>MA</given-names></name></person-group><article-title>Leukocyte adhesion molecules deficiency: its structural basis, pathophysiology and implications for modulating the inflammatory response</article-title><source>Immunol Rev</source><year>1990</year><volume>114</volume><fpage>145</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">1973407</pub-id><pub-id pub-id-type="doi">10.1111/j.1600-065X.1990.tb00564.x</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trowald-Wigh</surname><given-names>G</given-names></name><name><surname>Hakansson</surname><given-names>L</given-names></name><name><surname>Johannisson</surname><given-names>A</given-names></name><name><surname>Norrgren</surname><given-names>L</given-names></name><name><surname>Hard af Segerstad</surname><given-names>C</given-names></name></person-group><article-title>Leucocyte adhesion protein deficiency in Irish setter dogs</article-title><source>Vet Immunol Immunopathol</source><year>1992</year><volume>32</volume><fpage>261</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">1352926</pub-id><pub-id pub-id-type="doi">10.1016/0165-2427(92)90050-Z</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nagahata</surname><given-names>H</given-names></name><name><surname>Kehrli</surname><given-names>ME</given-names><suffix>Jr.</suffix></name><name><surname>Murata</surname><given-names>H</given-names></name><name><surname>Okada</surname><given-names>H</given-names></name><name><surname>Noda</surname><given-names>H</given-names></name><name><surname>Kociba</surname><given-names>GJ</given-names></name></person-group><article-title>Neurtrophil function and pathologic findings in Holstein calves with leukocyte adhesion deficiency</article-title><source>Am J Vet Res</source><year>1994</year><volume>55</volume><fpage>40</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">7908182</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hogg</surname><given-names>N</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>McDowall</surname><given-names>A</given-names></name><name><surname>Giles</surname><given-names>K</given-names></name><name><surname>Stanley</surname><given-names>P</given-names></name><name><surname>Laschinger</surname><given-names>M</given-names></name><name><surname>Henderson</surname><given-names>R</given-names></name></person-group><article-title>How T cells use LFA-1 to attach and migrate</article-title><source>Immunol Lett</source><year>2004</year><volume>92</volume><fpage>51</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">15081527</pub-id><pub-id pub-id-type="doi">10.1016/j.imlet.2003.10.014</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salas</surname><given-names>A</given-names></name><name><surname>Shimaoka</surname><given-names>M</given-names></name><name><surname>Kogan</surname><given-names>AN</given-names></name><name><surname>Harwood</surname><given-names>C</given-names></name><name><surname>von Andrian</surname><given-names>UH</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction</article-title><source>Immunity</source><year>2004</year><volume>20</volume><fpage>393</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">15084269</pub-id><pub-id pub-id-type="doi">10.1016/S1074-7613(04)00082-2</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>SR</given-names></name><name><surname>Sapru</surname><given-names>K</given-names></name><name><surname>Issekutz</surname><given-names>AC</given-names></name></person-group><article-title>The CD11/CD18 (beta2) integrins modulate neutrophil caspase activation and survival following TNF-alpha or endotoxin induced transendothelial migration</article-title><source>Immunol Cell Biol</source><year>2004</year><volume>82</volume><fpage>435</fpage><lpage>446</lpage><pub-id pub-id-type="pmid">15283855</pub-id><pub-id pub-id-type="doi">10.1111/j.0818-9641.2004.01268.x</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giblin</surname><given-names>PA</given-names></name><name><surname>Lemieux</surname><given-names>RM</given-names></name></person-group><article-title>LFA-1 as a key regulator of immune function: approaches toward the development of LFA-1-based therapeutics</article-title><source>Curr Pharm Des</source><year>2006</year><volume>12</volume><fpage>2771</fpage><lpage>2795</lpage><pub-id pub-id-type="pmid">16918410</pub-id><pub-id pub-id-type="doi">10.2174/138161206777947731</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kellersch</surname><given-names>B</given-names></name><name><surname>Kolanus</surname><given-names>W</given-names></name></person-group><article-title>Membrane-proximal signaling events in beta-2 integrin activation</article-title><source>Results Probl Cell Differ</source><year>2006</year><volume>43</volume><fpage>245</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">17068975</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xingyuan</surname><given-names>M</given-names></name><name><surname>Wenyun</surname><given-names>Z</given-names></name><name><surname>Tianwen</surname><given-names>W</given-names></name></person-group><article-title>Leukocyte function-associated antigen-1: structure, function and application prospects</article-title><source>Protein Pept Lett</source><year>2006</year><volume>13</volume><fpage>397</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">16712517</pub-id><pub-id pub-id-type="doi">10.2174/092986606775974429</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zecchinon</surname><given-names>L</given-names></name><name><surname>Fett</surname><given-names>T</given-names></name><name><surname>Vanden Bergh</surname><given-names>P</given-names></name><name><surname>Desmecht</surname><given-names>D</given-names></name></person-group><article-title>Bind another day: The LFA-1/ICAM-1 interaction as therapeutic target</article-title><source>Clin Appl Immunol Rev</source><year>2006</year><volume>6</volume><fpage>173</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.cair.2006.09.004</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>JR</given-names></name></person-group><article-title>Cell adhesion molecules in the pathogenesis of and host defence against microbial infection</article-title><source>Mol Pathol</source><year>1999</year><volume>52</volume><fpage>220</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">10694943</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Welch</surname><given-names>RA</given-names></name><name><surname>Dellinger</surname><given-names>EP</given-names></name><name><surname>Minshew</surname><given-names>B</given-names></name><name><surname>Falkow</surname><given-names>S</given-names></name></person-group><article-title>Haemolysin contributes to virulence of extra-intestinal E. coli infections</article-title><source>Nature</source><year>1981</year><volume>294</volume><fpage>665</fpage><lpage>667</lpage><pub-id pub-id-type="pmid">7031483</pub-id><pub-id pub-id-type="doi">10.1038/294665a0</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Welch</surname><given-names>RA</given-names></name></person-group><article-title>Pore-forming cytolysins of gram-negative bacteria</article-title><source>Mol Microbiol</source><year>1991</year><volume>5</volume><fpage>521</fpage><lpage>528</lpage><pub-id pub-id-type="pmid">2046545</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2958.1991.tb00723.x</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lally</surname><given-names>ET</given-names></name><name><surname>Kieba</surname><given-names>IR</given-names></name><name><surname>Sato</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>CL</given-names></name><name><surname>Rosenbloom</surname><given-names>J</given-names></name><name><surname>Korostoff</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>JF</given-names></name><name><surname>Shenker</surname><given-names>BJ</given-names></name><name><surname>Ortlepp</surname><given-names>S</given-names></name><name><surname>Robinson</surname><given-names>MK</given-names></name><name><surname>Billings</surname><given-names>PC</given-names></name></person-group><article-title>RTX toxins recognize a beta2 integrin on the surface of human target cells</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>30463</fpage><lpage>30469</lpage><pub-id pub-id-type="pmid">9374538</pub-id><pub-id pub-id-type="doi">10.1074/jbc.272.48.30463</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deshpande</surname><given-names>MS</given-names></name><name><surname>Ambagala</surname><given-names>TC</given-names></name><name><surname>Ambagala</surname><given-names>AP</given-names></name><name><surname>Kehrli</surname><given-names>ME</given-names><suffix>Jr.</suffix></name><name><surname>Srikumaran</surname><given-names>S</given-names></name></person-group><article-title>Bovine CD18 is necessary and sufficient to mediate Mannheimia (Pasteurella) haemolytica leukotoxin-induced cytolysis</article-title><source>Infect Immun</source><year>2002</year><volume>70</volume><fpage>5058</fpage><lpage>5064</lpage><pub-id pub-id-type="pmid">12183553</pub-id><pub-id pub-id-type="doi">10.1128/IAI.70.9.5058-5068.2002</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zecchinon</surname><given-names>L</given-names></name><name><surname>Fett</surname><given-names>T</given-names></name><name><surname>Desmecht</surname><given-names>D</given-names></name></person-group><article-title>How Mannheimia haemolytica defeats host defence through a kiss of death mechanism</article-title><source>Vet Res</source><year>2005</year><volume>36</volume><fpage>133</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">15720968</pub-id><pub-id pub-id-type="doi">10.1051/vetres:2004065</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bosse</surname><given-names>JT</given-names></name><name><surname>Janson</surname><given-names>H</given-names></name><name><surname>Sheehan</surname><given-names>BJ</given-names></name><name><surname>Beddek</surname><given-names>AJ</given-names></name><name><surname>Rycroft</surname><given-names>AN</given-names></name><name><surname>Kroll</surname><given-names>JS</given-names></name><name><surname>Langford</surname><given-names>PR</given-names></name></person-group><article-title>Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection</article-title><source>Microbes Infect</source><year>2002</year><volume>4</volume><fpage>225</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">11880056</pub-id><pub-id pub-id-type="doi">10.1016/S1286-4579(01)01534-9</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Losinger</surname><given-names>WC</given-names></name></person-group><article-title>Economic impacts of reduced pork production associated with the diagnosis of Actinobacillus pleuropneumoniae on grower/finisher swine operations in the United States</article-title><source>Prev Vet Med</source><year>2005</year><volume>68</volume><fpage>181</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">15820115</pub-id><pub-id pub-id-type="doi">10.1016/j.prevetmed.2004.12.004</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JK</given-names></name><name><surname>Schook</surname><given-names>LB</given-names></name><name><surname>Rutherford</surname><given-names>MS</given-names></name></person-group><article-title>Molecular cloning and characterization of the porcine CD18 leukocyte adhesion molecule</article-title><source>Xenotransplantation</source><year>1996</year><volume>3</volume><fpage>222</fpage><lpage>230</lpage></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vanden Bergh</surname><given-names>PG</given-names></name><name><surname>Fett</surname><given-names>T</given-names></name><name><surname>Zecchinon</surname><given-names>LL</given-names></name><name><surname>Thomas</surname><given-names>AV</given-names></name><name><surname>Desmecht</surname><given-names>DJ</given-names></name></person-group><article-title>The CD11a partner in Sus scrofa lymphocyte function-associated antigen-1 (LFA-1): mRNA cloning, structure analysis and comparison with mammalian homologues</article-title><source>BMC Vet Res</source><year>2005</year><volume>1</volume><fpage>5</fpage><pub-id pub-id-type="pmid">16216120</pub-id><pub-id pub-id-type="doi">10.1186/1746-6148-1-5</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vengust</surname><given-names>G</given-names></name><name><surname>Valencak</surname><given-names>Z</given-names></name><name><surname>Bidovec</surname><given-names>A</given-names></name></person-group><article-title>A serological survey of selected pathogens in wild boar in Slovenia</article-title><source>J Vet Med B Infect Dis Vet Public Health</source><year>2006</year><volume>53</volume><fpage>24</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">16460352</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>Adhesion receptors of the immune system</article-title><source>Nature</source><year>1990</year><volume>346</volume><fpage>425</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">1974032</pub-id><pub-id pub-id-type="doi">10.1038/346425a0</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Colombatti</surname><given-names>A</given-names></name><name><surname>Bonaldo</surname><given-names>P</given-names></name></person-group><article-title>The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms</article-title><source>Blood</source><year>1991</year><volume>77</volume><fpage>2305</fpage><lpage>2315</lpage><pub-id pub-id-type="pmid">2039815</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>A</given-names></name><name><surname>Leahy</surname><given-names>DJ</given-names></name></person-group><article-title>Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, alpha L beta 2) integrin</article-title><source>Proc Natl Acad Sci U S A</source><year>1995</year><volume>92</volume><fpage>10277</fpage><lpage>10281</lpage><pub-id pub-id-type="pmid">7479767</pub-id><pub-id pub-id-type="doi">10.1073/pnas.92.22.10277</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>CP</given-names></name><name><surname>Champe</surname><given-names>M</given-names></name><name><surname>Gonzalez</surname><given-names>T</given-names></name><name><surname>Wessinger</surname><given-names>ME</given-names></name><name><surname>Spencer</surname><given-names>SA</given-names></name><name><surname>Presta</surname><given-names>LG</given-names></name><name><surname>Berman</surname><given-names>PW</given-names></name><name><surname>Bodary</surname><given-names>SC</given-names></name></person-group><article-title>Identification of amino acids in the CD11a I-domain important for binding of the leukocyte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule-1 (ICAM-1)</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>12635</fpage><lpage>12640</lpage><pub-id pub-id-type="pmid">7539005</pub-id><pub-id pub-id-type="doi">10.1074/jbc.270.21.12635</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mould</surname><given-names>AP</given-names></name><name><surname>Humphries</surname><given-names>MJ</given-names></name></person-group><article-title>Regulation of integrin function through conformational complexity: not simply a knee-jerk reaction?</article-title><source>Curr Opin Cell Biol</source><year>2004</year><volume>16</volume><fpage>544</fpage><lpage>551</lpage><pub-id pub-id-type="pmid">15363805</pub-id><pub-id pub-id-type="doi">10.1016/j.ceb.2004.07.003</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>RS</given-names></name><name><surname>Corbi</surname><given-names>AL</given-names></name><name><surname>Berman</surname><given-names>L</given-names></name><name><surname>Springer</surname><given-names>T</given-names></name></person-group><article-title>Primary structure of the leukocyte function-associated molecule-1 alpha subunit: an integrin with an embedded domain defining a protein superfamily</article-title><source>J Cell Biol</source><year>1989</year><volume>108</volume><fpage>703</fpage><lpage>712</lpage><pub-id pub-id-type="pmid">2537322</pub-id><pub-id pub-id-type="doi">10.1083/jcb.108.2.703</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beglova</surname><given-names>N</given-names></name><name><surname>Blacklow</surname><given-names>SC</given-names></name><name><surname>Takagi</surname><given-names>J</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation</article-title><source>Nat Struct Biol</source><year>2002</year><volume>9</volume><fpage>282</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">11896403</pub-id><pub-id pub-id-type="doi">10.1038/nsb779</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rothlein</surname><given-names>R</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>The requirement for lymphocyte function-associated antigen 1 in homotypic leukocyte adhesion stimulated by phorbol ester</article-title><source>J Exp Med</source><year>1986</year><volume>163</volume><fpage>1132</fpage><lpage>1149</lpage><pub-id pub-id-type="pmid">3517218</pub-id><pub-id pub-id-type="doi">10.1084/jem.163.5.1132</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>C</given-names></name><name><surname>Shimaoka</surname><given-names>M</given-names></name><name><surname>Xiao</surname><given-names>T</given-names></name><name><surname>Schwab</surname><given-names>P</given-names></name><name><surname>Klickstein</surname><given-names>LB</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>The integrin alpha-subunit leg extends at a Ca2+-dependent epitope in the thigh/genu interface upon activation</article-title><source>Proc Natl Acad Sci U S A</source><year>2004</year><volume>101</volume><fpage>15422</fpage><lpage>15427</lpage><pub-id pub-id-type="pmid">15494438</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0406680101</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pardi</surname><given-names>R</given-names></name><name><surname>Bossi</surname><given-names>G</given-names></name><name><surname>Inverardi</surname><given-names>L</given-names></name><name><surname>Rovida</surname><given-names>E</given-names></name><name><surname>Bender</surname><given-names>JR</given-names></name></person-group><article-title>Conserved regions in the cytoplasmic domains of the leukocyte integrin alpha L beta 2 are involved in endoplasmic reticulum retention, dimerization, and cytoskeletal association</article-title><source>J Immunol</source><year>1995</year><volume>155</volume><fpage>1252</fpage><lpage>1263</lpage><pub-id pub-id-type="pmid">7636193</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loftus</surname><given-names>BJ</given-names></name><name><surname>Kim</surname><given-names>UJ</given-names></name><name><surname>Sneddon</surname><given-names>VP</given-names></name><name><surname>Kalush</surname><given-names>F</given-names></name><name><surname>Brandon</surname><given-names>R</given-names></name><name><surname>Fuhrmann</surname><given-names>J</given-names></name><name><surname>Mason</surname><given-names>T</given-names></name><name><surname>Crosby</surname><given-names>ML</given-names></name><name><surname>Barnstead</surname><given-names>M</given-names></name><name><surname>Cronin</surname><given-names>L</given-names></name><name><surname>Deslattes Mays</surname><given-names>A</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>RX</given-names></name><name><surname>Kang</surname><given-names>HL</given-names></name><name><surname>Mitchell</surname><given-names>S</given-names></name><name><surname>Eichler</surname><given-names>EE</given-names></name><name><surname>Harris</surname><given-names>PC</given-names></name><name><surname>Venter</surname><given-names>JC</given-names></name><name><surname>Adams</surname><given-names>MD</given-names></name></person-group><article-title>Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q</article-title><source>Genomics</source><year>1999</year><volume>60</volume><fpage>295</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">10493829</pub-id><pub-id pub-id-type="doi">10.1006/geno.1999.5927</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>NA</given-names></name><name><surname>Stebbing</surname><given-names>J</given-names></name><name><surname>Messier</surname><given-names>W</given-names></name></person-group><article-title>The potential significance of adaptive evolution and dimerization in chimpanzee intercellular cell adhesion molecules (ICAMs)</article-title><source>J Theor Biol</source><year>2005</year><volume>232</volume><fpage>339</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">15572059</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fett</surname><given-names>T</given-names></name><name><surname>Zecchinon</surname><given-names>L</given-names></name><name><surname>Baise</surname><given-names>E</given-names></name><name><surname>Desmecht</surname><given-names>D</given-names></name></person-group><article-title>Cloning and characterisation of the primary structure of the sheep lymphocyte function-associated antigen-1 alpha subunit</article-title><source>Mol Immunol</source><year>2005</year><volume>42</volume><fpage>1503</fpage><lpage>1508</lpage><pub-id pub-id-type="pmid">15950743</pub-id><pub-id pub-id-type="doi">10.1016/j.molimm.2005.01.005</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fett</surname><given-names>T</given-names></name><name><surname>Zecchinon</surname><given-names>L</given-names></name><name><surname>Baise</surname><given-names>E</given-names></name><name><surname>Desmecht</surname><given-names>D</given-names></name></person-group><article-title>The bovine (Bos taurus) CD11a-encoding cDNA: molecular cloning, characterisation and comparison with the human and murine glycoproteins</article-title><source>Gene</source><year>2004</year><volume>325</volume><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">14697514</pub-id><pub-id pub-id-type="doi">10.1016/j.gene.2003.09.043</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fett</surname><given-names>T</given-names></name><name><surname>Zecchinon</surname><given-names>LL</given-names></name><name><surname>Baise</surname><given-names>EA</given-names></name><name><surname>Desmecht</surname><given-names>DJ</given-names></name></person-group><article-title>Molecular characterisation of the caprine (Capra hircus) lymphocyte function-associated antigen-1 alpha subunit-encoding cDNA</article-title><source>BMC Vet Res</source><year>2005</year><volume>1</volume><fpage>4</fpage><pub-id pub-id-type="pmid">16216116</pub-id><pub-id pub-id-type="doi">10.1186/1746-6148-1-4</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>Y</given-names></name><name><surname>Tseng</surname><given-names>E</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>Cloning of the murine lymphocyte function-associated molecule-1 alpha-subunit and its expression in COS cells</article-title><source>J Immunol</source><year>1991</year><volume>147</volume><fpage>369</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">2051027</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dustin</surname><given-names>ML</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1</article-title><source>Nature</source><year>1989</year><volume>341</volume><fpage>619</fpage><lpage>624</lpage><pub-id pub-id-type="pmid">2477710</pub-id><pub-id pub-id-type="doi">10.1038/341619a0</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vitte</surname><given-names>J</given-names></name><name><surname>Pierres</surname><given-names>A</given-names></name><name><surname>Benoliel</surname><given-names>AM</given-names></name><name><surname>Bongrand</surname><given-names>P</given-names></name></person-group><article-title>Direct quantification of the modulation of interaction between cell- or surface-bound LFA-1 and ICAM-1</article-title><source>J Leukoc Biol</source><year>2004</year><volume>76</volume><fpage>594</fpage><lpage>602</lpage><pub-id pub-id-type="pmid">15240749</pub-id><pub-id pub-id-type="doi">10.1189/jlb.0204077</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Carman</surname><given-names>CV</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins</article-title><source>Science</source><year>2003</year><volume>301</volume><fpage>1720</fpage><lpage>1725</lpage><pub-id pub-id-type="pmid">14500982</pub-id><pub-id pub-id-type="doi">10.1126/science.1084174</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hibbs</surname><given-names>ML</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Stacker</surname><given-names>SA</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>Regulation of adhesion of ICAM-1 by the cytoplasmic domain of LFA-1 integrin beta subunit</article-title><source>Science</source><year>1991</year><volume>251</volume><fpage>1611</fpage><lpage>1613</lpage><pub-id pub-id-type="pmid">1672776</pub-id><pub-id pub-id-type="doi">10.1126/science.1672776</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Kooyk</surname><given-names>Y</given-names></name><name><surname>Binnerts</surname><given-names>ME</given-names></name><name><surname>Edwards</surname><given-names>CP</given-names></name><name><surname>Champe</surname><given-names>M</given-names></name><name><surname>Berman</surname><given-names>PW</given-names></name><name><surname>Figdor</surname><given-names>CG</given-names></name><name><surname>Bodary</surname><given-names>SC</given-names></name></person-group><article-title>Critical amino acids in the lymphocyte function-associated antigen-1 I domain mediate intercellular adhesion molecule 3 binding and immune function</article-title><source>J Exp Med</source><year>1996</year><volume>183</volume><fpage>1247</fpage><lpage>1252</lpage><pub-id pub-id-type="pmid">8642267</pub-id><pub-id pub-id-type="doi">10.1084/jem.183.3.1247</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Doerks</surname><given-names>T</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name><name><surname>Snel</surname><given-names>B</given-names></name></person-group><article-title>Domains in plexins: links to integrins and transcription factors</article-title><source>Trends Biochem Sci</source><year>1999</year><volume>24</volume><fpage>261</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">10390613</pub-id><pub-id pub-id-type="doi">10.1016/S0968-0004(99)01416-4</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>M</given-names></name><name><surname>Sundramurthy</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Tan</surname><given-names>SM</given-names></name><name><surname>Law</surname><given-names>SK</given-names></name><name><surname>Lescar</surname><given-names>J</given-names></name></person-group><article-title>The crystal structure of the plexin-semaphorin-integrin domain/hybrid domain/I-EGF1 segment from the human integrin beta2 subunit at 1.8-A resolution</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>30586</fpage><lpage>30593</lpage><pub-id pub-id-type="pmid">15965234</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M502525200</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Zang</surname><given-names>Q</given-names></name><name><surname>Takagi</surname><given-names>J</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>Structural and functional studies with antibodies to the integrin beta 2 subunit. A model for the I-like domain</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>21514</fpage><lpage>21524</lpage><pub-id pub-id-type="pmid">10779511</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M002286200</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takagi</surname><given-names>J</given-names></name><name><surname>Beglova</surname><given-names>N</given-names></name><name><surname>Yalamanchili</surname><given-names>P</given-names></name><name><surname>Blacklow</surname><given-names>SC</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>Definition of EGF-like, closely interacting modules that bear activation epitopes in integrin beta subunits</article-title><source>Proc Natl Acad Sci U S A</source><year>2001</year><volume>98</volume><fpage>11175</fpage><lpage>11180</lpage><pub-id pub-id-type="pmid">11572973</pub-id><pub-id pub-id-type="doi">10.1073/pnas.201420198</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Carman</surname><given-names>CV</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>Regulation of outside-in signaling and affinity by the beta2 I domain of integrin alphaLbeta2</article-title><source>Proc Natl Acad Sci U S A</source><year>2006</year><volume>103</volume><fpage>13062</fpage><lpage>13067</lpage><pub-id pub-id-type="pmid">16920795</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0605666103</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bleijs</surname><given-names>DA</given-names></name><name><surname>van Duijnhoven</surname><given-names>GC</given-names></name><name><surname>van Vliet</surname><given-names>SJ</given-names></name><name><surname>Thijssen</surname><given-names>JP</given-names></name><name><surname>Figdor</surname><given-names>CG</given-names></name><name><surname>van Kooyk</surname><given-names>Y</given-names></name></person-group><article-title>A single amino acid in the cytoplasmic domain of the beta 2 integrin lymphocyte function-associated antigen-1 regulates avidity-dependent inside-out signaling</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>10338</fpage><lpage>10346</lpage><pub-id pub-id-type="pmid">11134023</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M008967200</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shuster</surname><given-names>DE</given-names></name><name><surname>Bosworth</surname><given-names>BT</given-names></name><name><surname>Kehrli</surname><given-names>ME</given-names><suffix>Jr.</suffix></name></person-group><article-title>Sequence of the bovine CD18-encoding cDNA: comparison with the human and murine glycoproteins</article-title><source>Gene</source><year>1992</year><volume>114</volume><fpage>267</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">1351021</pub-id><pub-id pub-id-type="doi">10.1016/0378-1119(92)90586-E</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zecchinon</surname><given-names>L</given-names></name><name><surname>Fett</surname><given-names>T</given-names></name><name><surname>Baise</surname><given-names>E</given-names></name><name><surname>Desmecht</surname><given-names>D</given-names></name></person-group><article-title>Characterization of the caprine (Capra hircus) beta-2 integrin CD18-encoding cDNA and identification of mutations potentially responsible for the ruminant-specific virulence of Mannheimia haemolytica</article-title><source>Mol Membr Biol</source><year>2004</year><volume>21</volume><fpage>289</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">15513736</pub-id><pub-id pub-id-type="doi">10.1080/09687680412331282785</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zecchinon</surname><given-names>L</given-names></name><name><surname>Fett</surname><given-names>T</given-names></name><name><surname>Baise</surname><given-names>E</given-names></name><name><surname>Desmecht</surname><given-names>D</given-names></name></person-group><article-title>Molecular cloning and characterisation of the CD18 partner in ovine (Ovis aries) beta2-integrins</article-title><source>Gene</source><year>2004</year><volume>334</volume><fpage>47</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">15256254</pub-id><pub-id pub-id-type="doi">10.1016/j.gene.2004.03.011</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Brayton</surname><given-names>KA</given-names></name><name><surname>Lagerquist</surname><given-names>J</given-names></name><name><surname>Foreyt</surname><given-names>WJ</given-names></name><name><surname>Srikumaran</surname><given-names>S</given-names></name></person-group><article-title>Cloning and comparison of bighorn sheep CD18 with that of domestic sheep, goats, cattle, humans and mice</article-title><source>Vet Immunol Immunopathol</source><year>2006</year><volume>110</volume><fpage>11</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">16213032</pub-id><pub-id pub-id-type="doi">10.1016/j.vetimm.2005.08.030</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weitzman</surname><given-names>JB</given-names></name><name><surname>Wells</surname><given-names>CE</given-names></name><name><surname>Wright</surname><given-names>AH</given-names></name><name><surname>Clark</surname><given-names>PA</given-names></name><name><surname>Law</surname><given-names>SK</given-names></name></person-group><article-title>The gene organisation of the human beta 2 integrin subunit (CD18)</article-title><source>FEBS Lett</source><year>1991</year><volume>294</volume><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">1683838</pub-id><pub-id pub-id-type="doi">10.1016/0014-5793(91)81351-8</pub-id></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kijas</surname><given-names>JM</given-names></name><name><surname>Bauer</surname><given-names>TR</given-names><suffix>Jr.</suffix></name><name><surname>Gafvert</surname><given-names>S</given-names></name><name><surname>Marklund</surname><given-names>S</given-names></name><name><surname>Trowald-Wigh</surname><given-names>G</given-names></name><name><surname>Johannisson</surname><given-names>A</given-names></name><name><surname>Hedhammar</surname><given-names>A</given-names></name><name><surname>Binns</surname><given-names>M</given-names></name><name><surname>Juneja</surname><given-names>RK</given-names></name><name><surname>Hickstein</surname><given-names>DD</given-names></name><name><surname>Andersson</surname><given-names>L</given-names></name></person-group><article-title>A missense mutation in the beta-2 integrin gene (ITGB2) causes canine leukocyte adhesion deficiency</article-title><source>Genomics</source><year>1999</year><volume>61</volume><fpage>101</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">10512685</pub-id><pub-id pub-id-type="doi">10.1006/geno.1999.5948</pub-id></citation></ref><ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>RW</given-names></name><name><surname>O'Brien</surname><given-names>WE</given-names></name><name><surname>Beaudet</surname><given-names>AL</given-names></name></person-group><article-title>Nucleotide sequence of the cDNA from the mouse leukocyte adhesion protein CD18</article-title><source>Nucleic Acids Res</source><year>1989</year><volume>17</volume><fpage>5397</fpage><pub-id pub-id-type="pmid">2569711</pub-id><pub-id pub-id-type="doi">10.1093/nar/17.13.5397</pub-id></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bilsland</surname><given-names>CA</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>Cloning and expression of the chicken CD18 cDNA</article-title><source>J Leukoc Biol</source><year>1994</year><volume>55</volume><fpage>501</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">7908319</pub-id></citation></ref><ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Ainsworth</surname><given-names>AJ</given-names></name><name><surname>Noya</surname><given-names>M</given-names></name></person-group><article-title>Identification of a beta 2 (CD18) molecule in a teleost species, Ictalurus punctatus Rafinesque</article-title><source>Dev Comp Immunol</source><year>1999</year><volume>23</volume><fpage>571</fpage><lpage>583</lpage><pub-id pub-id-type="pmid">10579386</pub-id><pub-id pub-id-type="doi">10.1016/S0145-305X(99)00040-3</pub-id></citation></ref><ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamata</surname><given-names>T</given-names></name><name><surname>Tieu</surname><given-names>KK</given-names></name><name><surname>Tarui</surname><given-names>T</given-names></name><name><surname>Puzon-McLaughlin</surname><given-names>W</given-names></name><name><surname>Hogg</surname><given-names>N</given-names></name><name><surname>Takada</surname><given-names>Y</given-names></name></person-group><article-title>The role of the CPNKEKEC sequence in the beta(2) subunit I domain in regulation of integrin alpha(L)beta(2) (LFA-1)</article-title><source>J Immunol</source><year>2002</year><volume>168</volume><fpage>2296</fpage><lpage>2301</lpage><pub-id pub-id-type="pmid">11859118</pub-id></citation></ref><ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Salas</surname><given-names>A</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>Bistable regulation of integrin adhesiveness by a bipolar metal ion cluster</article-title><source>Nat Struct Biol</source><year>2003</year><volume>10</volume><fpage>995</fpage><lpage>1001</lpage><pub-id pub-id-type="pmid">14608374</pub-id><pub-id pub-id-type="doi">10.1038/nsb1011</pub-id></citation></ref><ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mould</surname><given-names>AP</given-names></name><name><surname>Barton</surname><given-names>SJ</given-names></name><name><surname>Askari</surname><given-names>JA</given-names></name><name><surname>Craig</surname><given-names>SE</given-names></name><name><surname>Humphries</surname><given-names>MJ</given-names></name></person-group><article-title>Role of ADMIDAS cation-binding site in ligand recognition by integrin alpha 5 beta 1</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>51622</fpage><lpage>51629</lpage><pub-id pub-id-type="pmid">14532288</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M306655200</pub-id></citation></ref><ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Takagi</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>C</given-names></name><name><surname>Xiao</surname><given-names>T</given-names></name><name><surname>Luo</surname><given-names>BH</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>The relative influence of metal ion binding sites in the I-like domain and the interface with the hybrid domain on rolling and firm adhesion by integrin alpha4beta7</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>55556</fpage><lpage>55561</lpage><pub-id pub-id-type="pmid">15448154</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M407773200</pub-id></citation></ref><ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chatila</surname><given-names>TA</given-names></name><name><surname>Geha</surname><given-names>RS</given-names></name><name><surname>Arnaout</surname><given-names>MA</given-names></name></person-group><article-title>Constitutive and stimulus-induced phosphorylation of CD11/CD18 leukocyte adhesion molecules</article-title><source>J Cell Biol</source><year>1989</year><volume>109</volume><fpage>3435</fpage><lpage>3444</lpage><pub-id pub-id-type="pmid">2574726</pub-id><pub-id pub-id-type="doi">10.1083/jcb.109.6.3435</pub-id></citation></ref><ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fagerholm</surname><given-names>SC</given-names></name><name><surname>Hilden</surname><given-names>TJ</given-names></name><name><surname>Nurmi</surname><given-names>SM</given-names></name><name><surname>Gahmberg</surname><given-names>CG</given-names></name></person-group><article-title>Specific integrin alpha and beta chain phosphorylations regulate LFA-1 activation through affinity-dependent and -independent mechanisms</article-title><source>J Cell Biol</source><year>2005</year><volume>171</volume><fpage>705</fpage><lpage>715</lpage><pub-id pub-id-type="pmid">16301335</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200504016</pub-id></citation></ref><ref id="B75"><citation citation-type="other"><article-title>Netprimer</article-title><ext-link ext-link-type="uri" xlink:href="[http://www.premierbiosoft.com/netprimer]"/></citation></ref><ref id="B76"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Rozen</surname><given-names>S</given-names></name><name><surname>Skaletsky</surname><given-names>HJ</given-names></name></person-group><article-title>Primer3 on the WWW for general users and for biologist programmers</article-title><source>Bioinformatics Methods and Protocols: Methods in Molecular Biology</source><year>2000</year><edition>Humana Press</edition><publisher-name>Totowa, Krawetz S., Misener S.</publisher-name><fpage>365</fpage><lpage>386</lpage></citation></ref><ref id="B77"><citation citation-type="other"><article-title>Chromas v2.21</article-title><ext-link ext-link-type="uri" xlink:href="[http://www.technelysium.com.au]"/></citation></ref><ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname><given-names>SF</given-names></name><name><surname>Gish</surname><given-names>W</given-names></name><name><surname>Miller</surname><given-names>W</given-names></name><name><surname>Myers</surname><given-names>EW</given-names></name><name><surname>Lipman</surname><given-names>DJ</given-names></name></person-group><article-title>Basic local alignment search tool</article-title><source>J Mol Biol</source><year>1990</year><volume>215</volume><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">2231712</pub-id></citation></ref><ref id="B79"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Nicholas</surname><given-names>B</given-names></name><name><surname>Karl</surname><given-names>B</given-names></name><name><surname>Nicholas</surname><given-names>P</given-names></name><name><surname>Hugh</surname><given-names>BJ</given-names></name></person-group><article-title>GeneDoc : a tool for editing and annotating multiple sequence alignements</article-title><ext-link ext-link-type="uri" xlink:href="[http://www.psc.edu/biomed/genedoc]"/></citation></ref><ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>H</given-names></name><name><surname>Engelbrecht</surname><given-names>J</given-names></name><name><surname>Brunak</surname><given-names>S</given-names></name><name><surname>von Heijne</surname><given-names>G</given-names></name></person-group><article-title>Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites</article-title><source>Protein Eng</source><year>1997</year><volume>10</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9051728</pub-id><pub-id pub-id-type="doi">10.1093/protein/10.1.1</pub-id></citation></ref><ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>LJ</given-names></name><name><surname>Gupta</surname><given-names>R</given-names></name><name><surname>Blom</surname><given-names>N</given-names></name><name><surname>Devos</surname><given-names>D</given-names></name><name><surname>Tamames</surname><given-names>J</given-names></name><name><surname>Kesmir</surname><given-names>C</given-names></name><name><surname>Nielsen</surname><given-names>H</given-names></name><name><surname>Staerfeldt</surname><given-names>HH</given-names></name><name><surname>Rapacki</surname><given-names>K</given-names></name><name><surname>Workman</surname><given-names>C</given-names></name><name><surname>Andersen</surname><given-names>CA</given-names></name><name><surname>Knudsen</surname><given-names>S</given-names></name><name><surname>Krogh</surname><given-names>A</given-names></name><name><surname>Valencia</surname><given-names>A</given-names></name><name><surname>Brunak</surname><given-names>S</given-names></name></person-group><article-title>Prediction of human protein function from post-translational modifications and localization features</article-title><source>J Mol Biol</source><year>2002</year><volume>319</volume><fpage>1257</fpage><lpage>1265</lpage><pub-id pub-id-type="pmid">12079362</pub-id><pub-id pub-id-type="doi">10.1016/S0022-2836(02)00379-0</pub-id></citation></ref><ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garnier</surname><given-names>J</given-names></name><name><surname>Gibrat</surname><given-names>JF</given-names></name><name><surname>Robson</surname><given-names>B</given-names></name></person-group><article-title>GOR method for predicting protein secondary structure from amino acid sequence</article-title><source>Methods Enzymol</source><year>1996</year><volume>266</volume><fpage>540</fpage><lpage>553</lpage><pub-id pub-id-type="pmid">8743705</pub-id></citation></ref></ref-list></back></article> 